Conduct and Transparency of Clinical Trialsicon

Tillotts is committed to sharing results from clinical trials on which regulatory decisions are based. At the same time, Tillotts values the privacy of patients and follows the guidelines set by the European Medicines Agency (EMA) on “publication and access to clinical-trial data”1 and European legislation on the protection of personal information that together call for the use of anonymised data, protect patients from retroactive identification and respect the boundaries set by patients’ informed consent.

All applicable Tillotts clinical trials are registered either on clinicaltrials.gov or other pertinent online registries according to global, regional and/or local guidelines.

1. http://www.ema.europa.eu/docs/en_GB/document_library/Other/2013/06/WC500144730.pdf